Inari Medical investors may receive additional information about the investigation by clicking the link "Submit Your Information" above.
Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of purchasers of Inari Medical ("Inari Medical") (NASDAQ: NARI) between May 21, 2020 and February 28, 2024.
On February 28, 2024, during after-market hours, Inari Medical announced that the company had received a civil investigative demand from the U.S. Department of Justice concerning an investigation under the federal Anti-Kickback Statute and Civil False Claims Act related to specific payments made to healthcare professionals.
Following this news, Inari Medical's stock fell $12.14 per share, or 20.8%, to close at $46.12 on February 29, 2024.
If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com.